0001171843-19-000335.txt : 20190117 0001171843-19-000335.hdr.sgml : 20190117 20190117164405 ACCESSION NUMBER: 0001171843-19-000335 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190117 FILED AS OF DATE: 20190117 DATE AS OF CHANGE: 20190117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEXO Corp. CENTRAL INDEX KEY: 0001690947 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38781 FILM NUMBER: 19531358 BUSINESS ADDRESS: STREET 1: 204-490 BOULEVARD SAINT-JOSEPH CITY: GATINEAU STATE: A8 ZIP: J8Y 3Y7 BUSINESS PHONE: 1-844-406-1852 MAIL ADDRESS: STREET 1: 204-490 BOULEVARD SAINT-JOSEPH CITY: GATINEAU STATE: A8 ZIP: J8Y 3Y7 FORMER COMPANY: FORMER CONFORMED NAME: Hydropothecary Corp DATE OF NAME CHANGE: 20161128 6-K 1 f6k_011719.htm FORM 6-K
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of January 2019

Commission File Number: 001-38781

HEXO Corp.
(Translation of registrant's name into English)

490 Boulevard St-Joseph, Suite 204
Gatineau, Québec, Canada J8Y 3Y7

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [   ]      Form 40-F [ X ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. 


On January 17, 2019, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

(c) Exhibit 99.1. Press release dated January 17, 2019


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

      HEXO Corp.    
  (Registrant)
   
  
Date: January 17, 2019     /s/ ED CHAPLIN    
  Ed Chaplin
  Chief Financial Officer
  
EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling

EXHIBIT 99.1

HEXO Corp. announces results of annual general meeting

GATINEAU, Quebec, Jan. 17, 2019 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX:HEXO) is pleased to announce the results of its annual general meeting of shareholders held on January 16, 2019. All items put forth at the meeting were approved, including the appointment of MNP LLP as auditor of the Company for the ensuing year, and the re-election of Nathalie Bourque, Vincent Chiara, Jason Ewart, Adam Miron, Dr. Michael Munzar and Sébastien St-Louis as directors of the Company, all with a majority of the votes cast, to hold office until the next annual meeting of shareholders or until their successors are elected or appointed. Results of the vote for the election of directors at the meeting are set out below:

NomineeTotal
Votes Cast
Votes For%Votes
Withheld
%
Nathalie Bourque28,303,68128,086,90099.2216,7810.8
Vincent Chiara28,303,68127,807,78398.2495,8981.8
Jason Ewart28,303,68128,097,18499.3206,4970.7
Adam Miron28,303,68128,137,45599.4166,2260.6
Dr. Michael Munzar28,303,68127,980,62098.9323,0611.1
Sébastien St-Louis28,303,68127,924,81299.4378,8690.6

A “Report of Voting Results” for the meeting will be available under the Company’s profile on SEDAR.

At the meeting, HEXO Corp. CEO Sebastien St-Louis announced that he was working on a CFO transition plan with the Company’s current CFO, Ed Chaplin. As HEXO Corp. turns its attention to the world, the focus will be on individuals with global consumer packaged goods company experience.

"Under Ed’s leadership, we built an exceptionally robust financial function which has enabled us to hit key significant milestones and to grow HEXO Corp. according to our vision. Ed was instrumental in making our initial public offering a reality. On our first day of trading, our company was valued at approximately $127.9M. Today, we are valued at over $1.2B,” said Sebastien St-Louis, CEO and co-founder of HEXO Corp. “Ed has been a valued and trusted advisor throughout his time at HEXO and has worked tirelessly to support me and the entire team during his tenure. I want to take this opportunity to thank him for his dedication and professionalism.”

As noted during the meeting, Mr. Chaplin plans to remain as Chief Financial Officer until April 30, 2019 and will also be available to offer support for six months following his departure to enable a smooth transition period.

Following the meeting, the Audit Committee and Human Resource and Corporate Governance Committee members were appointed to consist of Nathalie Bourque, Vincent Chiara and Jason Ewart, all independent directors.

About HEXO Corp.

HEXO Corp. is an award-winning consumer packaged goods cannabis company that creates and distributes award-winning products to serve the global cannabis market. Through our hub and spoke business strategy, we are partnering with Fortune 500 companies, bringing our brand value, cannabinoid isolation technology, licensed infrastructure and regulatory expertise to established companies, leveraging their distribution networks and capacity. As one of the largest licensed cannabis companies in Canada, HEXO Corp. operates with over 1.3 million sq. ft of facilities in Ontario and Quebec and a foothold in Greece to establish a Eurozone processing, production and distribution centre. We serve the Canadian adult-use market under the HEXO brand while continuing to provide our medical cannabis clients with consistent access to Hydropothecary medical cannabis products. For more information please visit hexocorp.com.

Forward-Looking Information

This press release may contain forward-looking information that is based on certain assumptions and involves known and unknown risks and uncertainties and other factors that could cause actual events to differ materially from current assumptions and expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. A more complete discussion of the risks and uncertainties facing the Company appears in the Company’s Annual Information Form and continuous disclosure filings, which are available on SEDAR’s website at www.sedar.com. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

Investor Relations:
Kathy Chow
1-866-438-8429
invest@HEXO.com
www.hexocorp.com

Media Relations:
Sarah Brown
(819) 317-0526
media@hexo.com

Director
Adam Miron
819-639-5498